Active ingredient
Mepolizumab
3 finished FDA listings contain Mepolizumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- MEPOLIZUMAB
- Dosage forms
- Injection, Powder, For Solution, Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 100 mg/ml · 40 mg/.4ml
- Brand names in FDA listings
- Nucala
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1720597
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 125526 | GLAXOSMITHKLINE LLC | 2015-11-04 | 1 |
| BLA 761122 | GLAXOSMITHKLINE | 2019-06-06 | 2 |
Official labeling on DailyMed
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.